UBS Group Cuts ArcBest (NASDAQ:ARCB) Price Target to $100.00

ArcBest (NASDAQ:ARCB – Free Report) had its target price cut by UBS Group from $110.00 to $100.00 in a report released on Monday morning,Benzinga reports. They currently have a neutral rating on the transportation company’s stock. A number of other analysts have also commented on ARCB. The Goldman Sachs Group dropped their price target on […]

Leave a Reply

Your email address will not be published.

Previous post BriaCell Therapeutics (NASDAQ:BCTX) Price Target Raised to $32.00
Next post Bank of England poised for interest rate cut amid slowdown concerns